0001274644-13-000056.txt : 20131121 0001274644-13-000056.hdr.sgml : 20131121 20131120201732 ACCESSION NUMBER: 0001274644-13-000056 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20131121 DATE AS OF CHANGE: 20131120 EFFECTIVENESS DATE: 20131121 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Ocera Therapeutics, Inc. CENTRAL INDEX KEY: 0001274644 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 631192270 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-206724 FILM NUMBER: 131234102 BUSINESS ADDRESS: STREET 1: 12651 HIGH BLUFF DRIVE STREET 2: SUITE 230 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 858-436-3900 MAIL ADDRESS: STREET 1: 12651 HIGH BLUFF DRIVE STREET 2: SUITE 230 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: TRANZYME INC DATE OF NAME CHANGE: 20031230 D 1 primary_doc.xml X0707 D LIVE 0001274644 Ocera Therapeutics, Inc. 525 University Avenue SUITE 610 Palo Alto CA CALIFORNIA 94301 650-475-0150 DELAWARE TRANZYME INC Corporation true Linda S Grais 525 University Avenue Suite 610 Palo Alto CA CALIFORNIA 94301 Director Jeryl L Hilleman 525 University Avenue Suite 610 Palo Alto CA CALIFORNIA 94301 Executive Officer Nina Kjellson 525 University Avenue Suite 610 Palo Alto CA CALIFORNIA 94301 Director Michael F Powell 525 University Avenue Suite 610 Palo Alto CA CALIFORNIA 94301 Director Pratik Shah 525 University Avenue Suite 610 Palo Alto CA CALIFORNIA 94301 Director Eckard Weber 525 University Avenue Suite 610 Palo Alto CA CALIFORNIA 94301 Director Lars G Ekman 525 University Avenue Suite 610 Palo Alto CA CALIFORNIA 94301 Director Jean-Paul Castaigne 525 University Avenue Suite 610 Palo Alto CA CALIFORNIA 94301 Director Franck S Rousseau 525 University Avenue Suite 610 Palo Alto CA CALIFORNIA 94301 Director David S Moore 525 University Avenue Suite 610 Palo Alto CA CALIFORNIA 94301 Executive Officer Anne M VanLent 525 University Avenue Suite 610 Palo Alto CA CALIFORNIA 94301 Director Biotechnology Decline to Disclose 06b false 2013-11-08 false true true false 0 Stifel, Nicolaus & Company Incorporated 793 None None 501 North Broadway St. Louis MO MISSOURI 63102 All States false Cowen & Company LLC 7616 None None 599 Lexington Avenue 20th Floor New York NY NEW YORK 10022 All States false 28000000 28000000 0 false 22 1380000 0 0 true The Issuer will use a portion of the gross proceeds for working capital and general corporate purposes, including payments to executive officers and directors in the ordinary course of business. false Ocera Therapeutics, Inc. /s/ Jeryl L. Hilleman Jeryl L. Hilleman Chief Financial Officer and Secretary 2013-11-20